NAD<sup>+</sup> improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway.

Zhao Y, Zhang J, Zheng Y, Zhang Y, Zhang XJ, Wang H, Du Y, Guan J, Wang X, Fu J. · 2021

Read NAD<sup>+</sup> improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway. by Zhao Y, Zhang J, Zheng Y, Zhang Y, Zhang XJ, Wang H, Du Y, Guan J, Wang X, Fu J. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8444613.txt.

Description

Zhao and co-authors test NAD+ as a guard for the brain in rats with chronic low blood flow. Poor brain blood flow feeds vascular dementia through microglia-driven inflammation. NAD+ had shown anti-inflammatory and antioxidant effects in other brain disease models, but not in this one.

Rats with blocked carotid arteries got daily NAD+ shots for 8 weeks. The treatment rescued learning and memory performance. It calmed brain inflammation by shielding mitochondria and cutting reactive oxygen output. Gene scans pointed to the Sirt1 and PGC-1alpha pathway. Cell tests with extra Sirt1 backed the finding. The work ties NAD+ gains to healthier mitochondria in microglia.

Catalog record

CREATORZhao Y, Zhang J, Zheng Y, Zhang Y, Zhang XJ, Wang H, Du Y, Guan J, Wang X, Fu J.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8444613

Browse the full library · About the Tower of Babel